Narrow search
Showing 1 - 10 of 91
Cover Image
Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? : a multivalued treatment effects analysis
Situ, Michael; Schwarz, Ute I.; Zou, Guangyong; … - In: The European journal of health economics 25 (2024) 3, pp. 397-409
Non-valvular atrial fibrillation (AF) is a common heart arrhythmia in the elderly population. AF patients are at high-risk of ischemic strokes, but oral anticoagulant (OAC) therapy reduces such risks. Warfarin had been the standard OAC for AF patients, however its effectiveness is highly...
Persistent link: https://www.econbiz.de/10014563793
Cover Image
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018
Morgan, Alice; Hartmanis, Sally; Tsochatzis, Emmanuel; … - In: The European journal of health economics 22 (2021) 4, pp. 505-518
Persistent link: https://www.econbiz.de/10012586496
Cover Image
Beyond price : the effects of non-financial barriers on access to drugs and health outcomes
Leporatti, Lucia; Levaggi, Rosella; Montefiori, Marcello - In: The European journal of health economics 22 (2021) 4, pp. 519-529
Persistent link: https://www.econbiz.de/10012586498
Cover Image
The cost of chemotherapy administration : a systematic review and meta-analysis
Sohi, Gursharan K.; Levy, Jordan; Delibasic, Victoria; … - In: The European journal of health economics 22 (2021) 4, pp. 605-620
Persistent link: https://www.econbiz.de/10012586526
Cover Image
Rising unemployment reduces the demand for healthcare services among people with cardiovascular disease : an Australian cohort study
Afoakwah, Clifford; Nghiem, Son; Scuffham, Paul A.; … - In: The European journal of health economics 22 (2021) 4, pp. 643-658
Persistent link: https://www.econbiz.de/10012586537
Cover Image
The "red herring" after 20 years : ageing and health care expenditures
Breyer, Friedrich; Lorenz, Normann - In: The European journal of health economics 22 (2021) 5, pp. 661-667
Persistent link: https://www.econbiz.de/10012586575
Cover Image
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 ex...
Barbier, Michaela Carla; Pardo, Esther; Panje, Cédric … - In: The European journal of health economics 22 (2021) 5, pp. 669-677
Persistent link: https://www.econbiz.de/10012586580
Cover Image
Regional medical practice variation in high-cost healthcare services : evidence from diagnostic imaging in Austria
Berger, Michael; Czypionka, Thomas - In: The European journal of health economics 22 (2021) 6, pp. 917-929
Persistent link: https://www.econbiz.de/10012586720
Cover Image
Different levels of care for follow-up of adults with congenital heart disease : a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency departmen...
Willems, Ruben; Ombelet, Fouke; Goossens, Eva; De … - In: The European journal of health economics 22 (2021) 6, pp. 951-960
Persistent link: https://www.econbiz.de/10012586730
Cover Image
Home sweet home : GPs' response to an increase in the fee size for home visits
O’Halloran, Jamie; Oxholm, Anne Sophie; Pedersen, … - In: The European journal of health economics 22 (2021) 6, pp. 977-989
Persistent link: https://www.econbiz.de/10012586737